DNA & Genetics Moleculent’s Early Access Program Tests Its Cell-Cell Mapping Tech on Immuno-OncologyBy adminNovember 9, 20250 When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a…
